Literature DB >> 16909252

Histologically verified lung metastases in benign giant cell tumours--14 cases from a single institution.

M Dominkus1, P Ruggieri, F Bertoni, A Briccoli, P Picci, M Rocca, M Mercuri.   

Abstract

From 1975 to 1997, 649 cases of benign giant cell tumours of the bone were treated at the Istituto Rizzoli. Fourteen patients (2.1%) experienced lung metastases after a mean of 35.2 months. The time interval between the diagnosis and the appearance of the lung metastases ranged from 3 months to 11.9 years. Metastasectomy was performed in all patients. Histologically, the metastases were identical to the primary bone lesions. Two patients with unresectable multiple metastases received additional chemotherapy. After a follow-up of 70 months (range: 8.2 to 185 months), all patients are alive. Ten patients showed no evidence of disease, one of these after a second resection of metastases, and four patients presented stable disease with multiple lung metastases. Local recurrence of the bone lesion occurred in seven patients before or simultaneously to the metastases. In contrast to previous reports, we could not detect a predominance of the distal radius, but all of the patients had a stage III tumour according to the Enneking criteria of benign lesions. We conclude that even metastatic benign giant cell tumours have an excellent prognosis after adequate resection. No prognostic factors despite high-grade lesions were detectable.

Entities:  

Mesh:

Year:  2006        PMID: 16909252      PMCID: PMC3172731          DOI: 10.1007/s00264-006-0204-x

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  16 in total

1.  Treatment of giant-cell tumor of bone.

Authors:  E W JOHNSON; D C DAHLIN
Journal:  J Bone Joint Surg Am       Date:  1959-07       Impact factor: 5.284

Review 2.  Giant-cell tumor of bone with pulmonary metastases. Six case reports and a review of the literature.

Authors:  F Bertoni; D Present; A Sudanese; N Baldini; P Bacchini; M Campanacci
Journal:  Clin Orthop Relat Res       Date:  1988-12       Impact factor: 4.176

3.  Metastatic giant-cell bone tumor in a man positive for HIV.

Authors:  A F List
Journal:  N Engl J Med       Date:  1988-02-25       Impact factor: 91.245

4.  Soft tissue recurrence of osteoclastoma.

Authors:  E Exarchou; J Maris; A Assimakopoulos
Journal:  J Bone Joint Surg Br       Date:  1989-05

5.  "Benign" giant cell tumor of bone metastasizing to lung.

Authors:  A A Gresen; D C Dahlin; L F Peterson; W S Payne
Journal:  Ann Thorac Surg       Date:  1973-11       Impact factor: 4.330

6.  Metastases from histologically benign giant-cell tumor of bone.

Authors:  M G Rock; D J Pritchard; K K Unni
Journal:  J Bone Joint Surg Am       Date:  1984-02       Impact factor: 5.284

7.  Clinical and immunohistochemical characteristics of benign giant cell tumour of bone with pulmonary metastases: case series.

Authors:  S Osaka; H Sugita; E Osaka; Y Yoshida; J Ryu; A Hemmi; K Suzuki
Journal:  J Orthop Surg (Hong Kong)       Date:  2004-06       Impact factor: 1.118

8.  Giant-cell tumor of bone.

Authors:  M Campanacci; N Baldini; S Boriani; A Sudanese
Journal:  J Bone Joint Surg Am       Date:  1987-01       Impact factor: 5.284

9.  Malignancy, aggressiveness, and recurrence in giant cell tumor of bone.

Authors:  N G Sanerkin
Journal:  Cancer       Date:  1980-10-01       Impact factor: 6.860

10.  Blood-borne spread of a benign giant cell tumor from the radius to the soft tissue of the hand.

Authors:  M A Joly; J J Vázquez; A Martinez; F J Guillen
Journal:  Cancer       Date:  1984-12-01       Impact factor: 6.860

View more
  43 in total

Review 1.  Giant cell tumor of bone: current treatment options.

Authors:  Keith M Skubitz
Journal:  Curr Treat Options Oncol       Date:  2014-09

2.  Denosumab does not decrease the risk of lung metastases from bone giant cell tumour.

Authors:  Shinji Tsukamoto; Andreas F Mavrogenis; Giulio Leone; Alberto Righi; Manabu Akahane; Piergiuseppe Tanzi; Akira Kido; Kanya Honoki; Yasuhito Tanaka; Davide Maria Donati; Costantino Errani
Journal:  Int Orthop       Date:  2018-08-11       Impact factor: 3.075

3.  Retrospective analysis of patients with rare-site and metastatic giant cell tumor.

Authors:  Junling Liu; Han Yang; Rui Sun; Zhijun Yang; Zhihua Zhu
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

Review 4.  The clinical approach toward giant cell tumor of bone.

Authors:  Lizz van der Heijden; P D Sander Dijkstra; Michiel A J van de Sande; Judith R Kroep; Remi A Nout; Carla S P van Rijswijk; Judith V M G Bovée; Pancras C W Hogendoorn; Hans Gelderblom
Journal:  Oncologist       Date:  2014-04-09

5.  Analysis of long-term outcome of image-guided volumetric modulated arc therapy (VMAT) for primary malignant tumor of the cervical spine.

Authors:  Ping Jiang; Xile Zhang; Weijuan Jiang; Na Meng; Abudureyimujiang Aili; Junjie Wang
Journal:  Cancer Biol Ther       Date:  2020-04-16       Impact factor: 4.742

6.  The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975-2004).

Authors:  Jennifer L Beebe-Dimmer; Karynsa Cetin; Jon P Fryzek; Scott M Schuetze; Kendra Schwartz
Journal:  Rare Tumors       Date:  2009-12-28

7.  A case of recurrent giant cell tumor of bone with malignant transformation and benign pulmonary metastases.

Authors:  Ira J Miller; Alan Blank; Suellen M Yin; Allison McNickle; Robert Gray; Steven Gitelis
Journal:  Diagn Pathol       Date:  2010-09-22       Impact factor: 2.644

Review 8.  Giant-cell tumor of bone, anti-RANKL therapy.

Authors:  Armelle Dufresne; Olfa Derbel; Philippe Cassier; Gualter Vaz; Anne-Valérie Decouvelaere; Jean-Yves Blay
Journal:  Bonekey Rep       Date:  2012-09-05

9.  What role for radiobiphosphonates bone scintigraphy in the monitoring of an unusual bone giant cell tumor: a case report and literature review.

Authors:  Salah Nabih Oueriagli; Imad Ghfir; Hassna El Guerrouj; Nouzha Ben Raïs
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-04-24

10.  Treatment options for recurrent giant cell tumors of bone.

Authors:  Maurice Balke; Helmut Ahrens; Arne Streitbuerger; Gabriele Koehler; Winfried Winkelmann; Georg Gosheger; Jendrik Hardes
Journal:  J Cancer Res Clin Oncol       Date:  2008-06-03       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.